InSiteOne has joined forces with France's Digital Share and France Telecom to launch Europe's first digital healthcare archiving service. Physicians using InSiteOne's InDex digital archive service in conjunction with Digital Share's clinical portal will
InSiteOne has joined forces with France's Digital Share and France Telecom to launch Europe's first digital healthcare archiving service. Physicians using InSiteOne's InDex digital archive service in conjunction with Digital Share's clinical portal will be able to access diagnostic images from any location. The service will be delivered over France Telecom's existing national data network. InSiteOne already provides secure online and near-line digital image storage and archiving services throughout the U.S. Using the portal, European doctors will be able to gain access instantly to all of a patient's medical records, including text, images, audio, and video, even if the records come from different medical centers and physician practices in the region.
2/28/01, Issue # 1504, page 2.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.